1. Market Research
  2. > Pathology
About 100 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Hepatocellular Carcinoma: Competitive Landscape to 2026

  • $ 3495
  • November 2018
  • 50 pages

Other oncology trials: ##% Ovarian Cancer NUMBER OF CLINICAL TRIALS ##, ## ##, ## ##, ## ##, ## ##, ## ##, ## ##, ## ##, ## ##, ## ##, ## Lymphoma Solid Tumor HCC: ##% Source: GlobalData, Pharma Intelligence Center [Accessed September 2018] Ovarian Cancer Multiple Myeloma Acute Myelocytic Leukemia Pro

  • Clinical Trial
  • Hepatitis
  • Lymphoma
  • Eli Lilly & Co.
  • Merck & Co., Inc.

Hepatitis Drugs Companies in China

  • $ 1800
  • April 2020
  • 63 pages

Hepatitis Drugs Companies in China Published by Asia Market Info and Dev Co.

  • Hepatitis
  • Lymphoma
  • Pharmaceutical
  • China
  • Sichuan Medco Pharmaceutical Stock Co., Ltd.

Hepatitis Drugs Markets in China

  • $ 4000
  • April 2020
  • 196 pages

Hepatitis Drugs Markets in China Asia Market Information and Development Co.

  • Hepatitis
  • Lymphoma
  • Pharmaceutical
  • China
  • Sichuan Medco Pharmaceutical Stock Co., Ltd.

The Biopharmaceutical Industry in 2018: Key Events and Trends to Watch for by Therapy Area

  • $ 500
  • March 2018
  • 55 pages

The Phase III PHOENIX trial, testing the addition of Imbruvica to the current SOC, R- CHOP, in frontline diffuse large B-cell lymphoma (DLBCL) is expected read out in mid- 2018.

  • Hepatitis
  • Infectious Disease
  • Lymphoma
  • Therapy
  • United States

Biotech Serum, Blood, Plasma: Market Shares, Market Strategies, and Market Forecasts, 2018 to 2024

  • $ 4300
  • October 2018
  • 338 pages

Doctors can use the blood to treat patients suffering from a variety of diseases, including lymphoma and anemia. into storage.

  • Blood Supply
  • Hepatitis
  • Lymphoma
  • China
  • East Asia

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19

  • $ 4995
  • November 2016
  • 183 pages

The ZUMA-## trial included patients with refractory diffuse large B-cell lymphoma, primary mediastinal Bcell lymphoma and transformed follicular lymphoma.

  • Cancer Immunotherapy
  • Hepatitis
  • Lymphoma
  • Therapy
  • Vaccine

Cyclin Dependent Kinase 4 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 173 pages

As a third line therapy for follicular lymphoma (FL), mantle cell lymphoma (MCL), marginal zone lymphoma (MZL), small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia(CLL), diffuse large B-cell lymphoma (DLBCL) and relapsed/ refractory acute m

  • Breast Cancer
  • Hepatitis
  • Lymphoma
  • Pharmaceutical
  • Therapy

Cyclin Dependent Kinase 6 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 168 pages

As a third line therapy for follicular lymphoma (FL), mantle cell lymphoma (MCL), marginal zone lymphoma (MZL), small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia(CLL), diffuse large B-cell lymphoma (DLBCL) and relapsed/ refractory acute m

  • Breast Cancer
  • Hepatitis
  • Lymphoma
  • Pharmaceutical
  • Therapy

Gallbladder Cancer - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 695 pages

There were ## patients with indolent lymphoma, including chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), marginal zone lymphoma (MZL), and Waldenström' s macroglobulinemia (WM), and ## patients with aggressive lymphoma, including diffuse large B-

  • Cancer
  • Hepatitis
  • Lung Cancer
  • Lymphoma
  • Therapy

Kaposi Sarcoma - Pipeline Review, H1 2020

  • $ 2000
  • March 2020
  • 294 pages

IT IS IN PHASE I STAGE OF DEVELOPMENT FOR DIFFUSE LARGE B CELL LYMPHOMA AND HIGH-GRADE B CELL LYMPHOMA.

  • Chemotherapy
  • Hepatitis
  • Hospital
  • Lymphoma
  • Therapy

Arrowhead Research Corporation (USA)

  • $ 2950
  • January 2016
  • 61 pages

Lymphoma-Burkitt Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Immunodeficiency-Associated Lymphoproliferative Disorders, Lymphoplasmacytic Lymphoma, Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Mediastinal (Thymic) Large B-Cell

  • Hepatitis
  • Infectious Disease
  • Lymphoma
  • Pathology
  • Market Shares

Histone Deacetylase 2 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 144 pages

It is in Phase I stage of development for the treatment of relapsed or refractory B-cell non- Hodgkin lymphoma including diffuse large B-Cell lymphoma, follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma, transformed indolent lymphoma and mu

  • Cancer
  • Hepatitis
  • Lymphoma
  • Pharmaceutical
  • Therapy

Histone Deacetylase 1 - Pipeline Review, H1 2020

  • $ 3500
  • April 2020
  • 167 pages

IT IS IN PHASE I STAGE OF DEVELOPMENT FOR THE TREATMENT OF RELAPSED OR REFRACTORY B-CELL NON- HODGKIN LYMPHOMA INCLUDING DIFFUSE LARGE B-CELL LYMPHOMA, FOLLICULAR LYMPHOMA, MANTLE CELL LYMPHOMA, MARGINAL ZONE LYMPHOMA, TRANSFORMED INDOLENT LYMPHOMA AND MU

  • Hepatitis
  • Lymphoma
  • Pharmaceutical
  • Targeted Therapy
  • Therapy

Gilead Sciences Inc (GILD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 285 pages

Specific types include large B-cell lymphoma (DLBCL), primary mediastinal large B-cell lymphoma (PMBCL), high-grade B-cell lymphoma, and DLBCL arising from follicular lymphoma (transformed follicular lymphoma, or TFL).

  • Hepatitis
  • HIV AIDS
  • Lymphoma
  • Pharmaceutical
  • Therapy

Cyclin Dependent Kinase 7 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 69 pages

In September 2012, Tragara Pharmaceuticals registered a Phase I trial of TG-## for the treatment of relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma.

  • Hepatitis
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • United States

Chondrosarcoma - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 481 pages

THE DRUG CANDIDATE IS IN PHASE I STAGE OF DEVELOPMENT FOR DIFFUSE LARGE B CELL LYMPHOMA, MANTLE CELL LYMPHOMA, MARGINAL ZONE LYMPHOMA (THIRD LINE THERAPY).

  • Chemotherapy
  • Hepatitis
  • Hospital
  • Lymphoma
  • Therapy

High Affinity Nerve Growth Factor Receptor - Pipeline Review, H1 2020

  • $ 3500
  • January 2020
  • 138 pages

IT IS IN PHASE II FOR ANAPLASTIC LARGE CELL LYMPHOMA, LEPTOMENINGEAL DISEASE, METASTATIC PANCREATIC CANCER, CHOLANGIOCARCINOMA, PAPILLARY THYROID CANCER, TRIPLE NEGATIVE, HER-## POSITIVE, ER OR PR POSITIVE BREAST CANCER AND METASTATIC MELANOMA.

  • Cancer
  • Hepatitis
  • Lung Cancer
  • Lymphoma
  • Therapy

Rhabdomyosarcoma - Pipeline Review, H1 2020

  • $ 2000
  • March 2020
  • 421 pages

The hematologic cancers to be studied include multiple myeloma (MM), chronic lymphocytic leukemia/ small lymphocytic lymphoma (CLL/ SLL), lymphoplasmacytic lymphoma (LPL), marginal zone lymphoma (MZL), mantle cell lymphoma (MCL), and potentially diffuse la

  • Hepatitis
  • Hospital
  • Lymphoma
  • Targeted Therapy
  • Therapy

Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H2 2018

  • $ 3500
  • September 2018
  • 150 pages

It is in Phase I stage of development for the treatment of relapsed or refractory B-cell non-Hodgkin lymphoma including diffuse large B-Cell lymphoma, follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma, transformed indolent lymphoma and mul

  • Hepatitis
  • Lymphoma
  • Oncology
  • Pharmaceutical
  • Therapy

Nasopharyngeal Cancer - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 688 pages

There were ## patients with indolent lymphoma, including chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), marginal zone lymphoma (MZL), and Waldenström' s macroglobulinemia (WM), and ## patients with aggressive lymphoma, including diffuse large B-

  • Cancer
  • Hepatitis
  • Lymphoma
  • Therapy
  • United States
View report >

Hepatitis Statistics in Australia

  • December 2016
  • 72 pages

SECTION ## : LIVER TRANSPLANTATION AND CANCER Adult Child ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##y ##-##y ##-##y ##-##y > ##y ## cancers in ## pts (##% of all pts) Time to Diagnosis of Lymphoma (##m - > ##yrs) Lymphoma - Adults n= ## (##% adults with de novo Ca)

  • Cancer
  • Hepatitis
  • Lymphoma
  • Pathology
  • Australia

Hepatitis Statistics January 2019

Hepatitis Statistics January 2018

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on